The 5 most recent market catalysts affecting $HIMX, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Nov 6, 2026
Corporate Catalyst
Bearish
Impact 85
Himax Technologies, Inc. Reports Third Quarter 2026 Financial Results and Provides Fourth Quarter 2026 Guidance
Himax Technologies reported a strong third quarter, exceeding analyst expectations for EPS and demonstrating robust year-over-year and sequential revenue growth. This positive perf…
Oct 14, 2026
Corporate Catalyst
Neutral
Impact 65
Himax Technologies Announces That Its WiseEye Ultralow Power AI Processor, HX6538, Has Been Integrated Into Alibaba’s Latest Qwen Glasses N1 Product
Himax Technologies (HIMX) has secured a significant design win by having its WiseEye AI processor integrated into Alibaba's (BABA) new Qwen Glasses N1. This matters because it vali…
Aug 18, 2026
Corporate Catalyst
Neutral
Impact 65
Himax Technologies shares are trading lower. The company announced its WiseEye palm vein biometric authentication technology has been integrated into the WAFERLOCK L322 palm vein smart lock.
The headline presents a paradox: positive product integration news for Himax Technologies (HIMX) is met with a decline in its stock price. This suggests that either the market had …
Aug 6, 2026
Corporate Catalyst
Neutral
Impact 75
Himax Techs Sees Q3 GAAP EPS $0.08-$0.10 vs $0.05 Est; Sees Sales $243.288M-$252.383M vs $235.300M Est
Himax Technologies announced Q3 GAAP EPS guidance of $0.08-$0.10, notably higher than the analyst estimate of $0.05. Similarly, the company's sales guidance of $243.288 million-$25…
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 92
Himax Technologies Q2 EPS $0.11 Misses $0.12 Estimate, Sales $227.372M Beat $223.000M Estimate
Himax Technologies' Q2 earnings report presents a mixed picture. While the company's sales exceeded analyst expectations and showed healthy year-over-year growth, the earnings per …
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.